Skip to contentSkip to filters

We use cookies for analytics.

Topic: mTOR pathway

Seminar
3 seminars
ePoster
1 ePoster

In Developmental Neuroscience and Molecular Neuroscience

Seminar · Neuroscience

Myelin Formation and Oligodendrocyte Biology in Epilepsy

Angelika Mühlebner · Universitair Medisch Centrum Utrecht

Thu, Feb 16, 2023 · 18:00 UTC

Epilepsy is one of the most common neurological diseases according to the World Health Organization (WHO) affecting around 70 million people worldwide [WHO]. Patients who suffer from epilepsy also suffer from a variety of neuro-psychiatric co-morbidities, which they can experience as crippling as the seizure condition itself. Adequate organization of cerebral white matter is utterly important for cognitive development. The failure of integration of neurologic function with cognition is reflected in neuro-psychiatric disease, such as autism spectrum disorder (ASD). However, in epilepsy we know

Seminar · Neuroscience

Myelin Formation and Oligodendrocyte Biology in Epilepsy

Angelika Mühlebner · Universitair Medisch Centrum Utrecht

Wed, Oct 19, 2022 · 18:00 UTC

Epilepsy is one of the most common neurological diseases according to the World Health Organization (WHO) affecting around 70 million people worldwide [WHO]. Patients who suffer from epilepsy also suffer from a variety of neuro-psychiatric co-morbidities, which they can experience as crippling as the seizure condition itself. Adequate organization of cerebral white matter is utterly important for cognitive development. The failure of integration of neurologic function with cognition is reflected in neuro-psychiatric disease, such as autism spectrum disorder (ASD). However, in epilepsy we know

Seminar · Neuroscience

Understanding and treating epilepsy in tuberous sclerosis complex

Angelique Bordey · Yale University

Wed, May 5, 2021 · 16:00 UTC

Tuberous sclerosis complex (TSC) and focal cortical dysplasia type II (FCDII) are caused by mutations in mTOR pathway genes leading to mTOR hyperactivity, focal malformations of cortical development (fMCD), and seizures in 80-90% of the patients. The current definitive treatments for epilepsy are surgical resection or treatment with everolimus, which inhibits mTOR activity (only approved for TSC). Because both options have severe limitations, there is a major need to better understand the mechanisms leading to seizures to improve life-long epilepsy treatment in TSC and FCDII. To investigate su

ePoster · Neuroscience

Modulation of AKT and ribosomal S6 protein phosphorylation by dopamine receptors and cyclic AMP in the developing retina

Roberto Paes-de-Carvalho, Lohan Ximenes, Arthur Barbieri · FENS Forum 2024

Dopamine-dependent cyclic AMP accumulation occurs via activation of D1-like receptors since early development of the chicken retina. Cyclic AMP is an ubiquitous second messenger that regulates several physiological processes including neuronal survival and differentiation. The mTOR pathway is a crucial pathway linking cellular metabolism to protein synthesis. The mTORC1 and 2 signaling complexes are composed of mTOR and distinct proteins, and while mTORC1 is regulated by AKT, mTORC2 is upstream of this enzyme and regulates phosphorylation of its serine 473 residue. Ribosomal protein S6 (RpS6)